CatalystXR - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Damien Eley of The Many and Jamie Gilroy of CatalystXR following The Many’s majority-stake acquisition, a deal that signals how immersive technology is becoming central to participation-led agency growth.

Read More

Technology Industry News

The Many expands participation strategy with CatalystXR acquisition and immersive technology push

The Many has acquired a majority stake in CatalystXR. Read why this XR deal could reshape agency competition, immersive services, and participation strategy.

April 21, 2026

web analytics